Suzhou CellPro Biotechnology Co., Ltd.
PrivateLast Round
Series B
Sep 18, 2022
Company Overview
Suzhou CellPro Biotechnology Co., Ltd. is a life science company that develops, manufactures, and sells high-end biomedical plastic consumables for molecular diagnosis, cell culture, and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou CellPro Biotechnology Co., Ltd. Comparables
Compare Suzhou CellPro Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuxi NEST Biotechnology Co., Ltd. | 89% | |
| Zhejiang Sorfa Life Science Research Co., Ltd. | 87% | |
| Yongyue Medical Technology (Kunshan) Co., Ltd. | 87% |
Suzhou CellPro Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 18, 2022 | ||||
| Series A Extension | Mar 30, 2022 | ||||
| Series A | Aug 1, 2021 | ||||
| Angel | Feb 1, 2020 |
Suzhou CellPro Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 顺融资本 | Series A, Series A Extension, Series B |
| Oriza Holdings | Series A, Series A Extension, Series B |
| YuanBio Venture Capital | Series B |
| CICC Capital | Series B |
| Sunshine Insurance Group | Series A Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2022
Led by CICC Capital and YuanBio Venture Capital.
- Mar 30, 2022
Raised Series A Extension with Oriza Holdings and Sunshine Insurance Group.
Suzhou CellPro Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Suzhou CellPro Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Suzhou CellPro Biotechnology Co., Ltd. a public or private company?
Suzhou CellPro Biotechnology Co., Ltd. is a private company.
What is the current stock price of Suzhou CellPro Biotechnology Co., Ltd.?
Suzhou CellPro Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks Suzhou CellPro Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Suzhou CellPro Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Suzhou CellPro Biotechnology Co., Ltd. is not publicly available.
Can I buy Suzhou CellPro Biotechnology Co., Ltd. stock?
Suzhou CellPro Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Suzhou CellPro Biotechnology Co., Ltd.'s last funding round?
Suzhou CellPro Biotechnology Co., Ltd.'s most recent funding round was Series B on September 18, 2022.
Who are the main investors in Suzhou CellPro Biotechnology Co., Ltd.?
Key investors in Suzhou CellPro Biotechnology Co., Ltd. include YuanBio Venture Capital, CICC Capital.
Will Suzhou CellPro Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Suzhou CellPro Biotechnology Co., Ltd..
How can I track Suzhou CellPro Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suzhou CellPro Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.